Movers and Shakers
Adam Crystal, most recently oncology lead at the Novartis Institute for BioMedical Research, is the new CMO of C4 Therapeutics
The post-antibiotic era
We are currently witnessing the emergence of an ever-growing number of microbes that have become resistant to most or all existing drugs designed to act against them.
The book of revelation
Chemists are normally reticent when it comes to talking about chemical topics with their friends because such subjects generally lack the necessary human interest.
Innovation in polymers
Robin Harrison is Synthomer’s global innovation director for the international FTSE 250 listed company.
Fixing Carbon Capture
Meeting new targets on climate change will mean both reducing CO2 emissions to zero
Gaining the edge
In his investigation of value management, Phil Allen examines value-based differentiation as a key to building a sustainable competitive position in the market
Business digest
Chemicals major BASF has opened a research centre for catalyst and process development at its Verbund site
I2 robot
Chemists have developed a digital platform that enables chemical syntheses to be programmed and to proceed without human intervention